Xencor

Xencor

World Rank (Aug-2026)
6884
Market Cap (Aug-2026)
1.735 Billion USD
Market Cap (Mar-08-2026)
0.830 Billion USD
World Rank (Jan-05-2024)
7,236
Market Cap (Jan-05-2024)
1.346 Billion USD
World Rank (Jul-30-2023)
7,028
Market Cap (Jul-30-2023)
1.449 Billion USD
World Rank (Jan-07-2022)
5,875
Market Cap (Jan-07-2022)
2.221 Billion USD
World Rank (Jan-01-2021)
4,800
Market Cap (Jan-01-2021)
2.507 Billion USD
Headquarters Country
USA
Top Healthcare Companies in USA
Nasdaq / NYSE Code
XNCR
Employee Count
254
Employee Count as of Date
As on 2021
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
126 Million USD
Annual Operating Income in USD
-178 Million USD
Annual Net Income in USD
-92 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
875 Million USD
Total Liabilities in USD
240 Million USD
Total Equity in USD
636 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
HealthCare Products
Biotechnology
Biopharmaceutical
Company Website
XENCOR INC
Yahoo
Yahoo @ Nasdaq
Company Profile
Xencor is a Clinical Stage Biopharmaceutical company. It has portfolio of 18 proprietary and partnered therapeutic antibody and cytokine programs in clinical development for the treatment of cancer autoimmune disorders and infectious disease. The headquarters is in USA.
Facts About Company
As on 2021, Xencor had 254 full-time employees.
Founded Year
1997
IPO Year
2013
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share